TY - JOUR
T1 - Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football
AU - Mez, Jesse
AU - Daneshvar, Daniel H
AU - Kiernan, Patrick T
AU - Abdolmohammadi, Bobak
AU - Alvarez, Victor E
AU - Huber, Bertrand R
AU - Alosco, Michael L
AU - Solomon, Todd M
AU - Nowinski, Christopher J
AU - McHale, Lisa
AU - Cormier, Kerry A
AU - Kubilus, Caroline A
AU - Martin, Brett M
AU - Murphy, Lauren
AU - Baugh, Christine M
AU - Montenigro, Phillip H
AU - Chaisson, Christine E
AU - Tripodis, Yorghos
AU - Kowall, Neil W
AU - Weuve, Jennifer
AU - McClean, Michael D
AU - Cantu, Robert C
AU - Goldstein, Lee E
AU - Katz, Douglas I
AU - Stern, Robert A
AU - Stein, Thor D
AU - McKee, Ann C
PY - 2017/7/25
Y1 - 2017/7/25
N2 - Importance: Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE).Objective: To determine the neuropathological and clinical features of deceased football players with CTE.Design, Setting, and Participants: Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history.Exposures: Participation in American football at any level of play.Main Outcomes and Measures: Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia.Results: Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia.Conclusions and Relevance: In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.
AB - Importance: Players of American football may be at increased risk of long-term neurological conditions, particularly chronic traumatic encephalopathy (CTE).Objective: To determine the neuropathological and clinical features of deceased football players with CTE.Design, Setting, and Participants: Case series of 202 football players whose brains were donated for research. Neuropathological evaluations and retrospective telephone clinical assessments (including head trauma history) with informants were performed blinded. Online questionnaires ascertained athletic and military history.Exposures: Participation in American football at any level of play.Main Outcomes and Measures: Neuropathological diagnoses of neurodegenerative diseases, including CTE, based on defined diagnostic criteria; CTE neuropathological severity (stages I to IV or dichotomized into mild [stages I and II] and severe [stages III and IV]); informant-reported athletic history and, for players who died in 2014 or later, clinical presentation, including behavior, mood, and cognitive symptoms and dementia.Results: Among 202 deceased former football players (median age at death, 66 years [interquartile range, 47-76 years]), CTE was neuropathologically diagnosed in 177 players (87%; median age at death, 67 years [interquartile range, 52-77 years]; mean years of football participation, 15.1 [SD, 5.2]), including 0 of 2 pre-high school, 3 of 14 high school (21%), 48 of 53 college (91%), 9 of 14 semiprofessional (64%), 7 of 8 Canadian Football League (88%), and 110 of 111 National Football League (99%) players. Neuropathological severity of CTE was distributed across the highest level of play, with all 3 former high school players having mild pathology and the majority of former college (27 [56%]), semiprofessional (5 [56%]), and professional (101 [86%]) players having severe pathology. Among 27 participants with mild CTE pathology, 26 (96%) had behavioral or mood symptoms or both, 23 (85%) had cognitive symptoms, and 9 (33%) had signs of dementia. Among 84 participants with severe CTE pathology, 75 (89%) had behavioral or mood symptoms or both, 80 (95%) had cognitive symptoms, and 71 (85%) had signs of dementia.Conclusions and Relevance: In a convenience sample of deceased football players who donated their brains for research, a high proportion had neuropathological evidence of CTE, suggesting that CTE may be related to prior participation in football.
KW - Adult
KW - Aged
KW - Athletes
KW - Athletic Injuries
KW - Brain
KW - Brain Concussion
KW - Cause of Death
KW - Chronic Traumatic Encephalopathy
KW - Cognition Disorders
KW - Football
KW - Humans
KW - Male
KW - Mental Disorders
KW - Middle Aged
KW - Severity of Illness Index
KW - Substance-Related Disorders
KW - United States
KW - tau Proteins
KW - Journal Article
KW - Research Support, N.I.H., Extramural
KW - Research Support, U.S. Gov't, Non-P.H.S.
U2 - 10.1001/jama.2017.8334
DO - 10.1001/jama.2017.8334
M3 - Journal article
C2 - 28742910
SN - 0002-9955
VL - 318
SP - 360
EP - 370
JO - JAMA - Journal of the American Medical Association
JF - JAMA - Journal of the American Medical Association
IS - 4
ER -